Milatuzumab

From WikiMD.org
Jump to navigation Jump to search
Milatuzumab
TermMilatuzumab
Short definitionMilatuzumab - (pronounced) (MIH-luh-TOO-zoo-mab) A substance being studied for the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other cell types. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Milatuzumab - (pronounced) (MIH-luh-TOO-zoo-mab) A substance being studied for the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other cell types. It can help kill cancer cells. Milatuzumab is a type of monoclonal antibody. Also called hLL1 and IMMU-110

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski